Triple Therapy Tied to Reduced Rate of COPD Exacerbations

Share this content:
Triple Therapy Tied to Reduced Rate of COPD Exacerbations
Triple Therapy Tied to Reduced Rate of COPD Exacerbations

WEDNESDAY, April 18, 2018 (HealthDay News) -- For patients with chronic obstructive pulmonary disease (COPD), triple therapy is associated with a reduced rate of exacerbations, according to a study published online April 18 in the New England Journal of Medicine.

David A. Lipson, M.D., from GlaxoSmithKline in Collegeville, Pa., and colleagues conducted a randomized trial involving 10,355 patients with COPD. Fifty-two weeks of a once-daily combination of fluticasone furoate (an inhaled glucocorticoid), umeclidinium (a long-acting muscarinic antagonist), and vilanterol (a long-acting β2-agonist) was compared with fluticasone furoate-vilanterol and umeclidinium-vilanterol. Each of the regimens was administered in a single inhaler.

The researchers found that the rate of moderate or severe exacerbations was 0.91 per year in the triple-therapy group, compared with 1.07 in the fluticasone furoate-vilanterol group (rate ratio with triple therapy, 0.85) and 1.21 in the umeclidinium-vilanterol group (rate ratio with triple therapy, 0.75). The annual rate of severe exacerbations resulting in hospitalization was 0.13 in the triple therapy group, compared with 0.19 in the umeclidinium-vilanterol group (rate ratio, 0.66). The incidence of pneumonia was higher in the inhaled-glucocorticoid groups than in the umeclidinium-vilanterol group. A significantly higher risk of clinician-diagnosed pneumonia was seen with triple therapy versus umeclidinium-vilanterol (hazard ratio, 1.53).

"Triple therapy with fluticasone furoate, umeclidinium, and vilanterol resulted in a lower rate of moderate or severe COPD exacerbations than fluticasone furoate-vilanterol or umeclidinium-vilanterol in this population," the authors write.

Several authors disclosed financial ties to GlaxoSmithKline, which funded the study.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »